Ivermectin Study’s Negative Conclusion is at Odds With Its Findings of Significant Clinical Benefit

Will Jones

A new study on cheap, repurposed Covid treatment ivermectin has concluded that its findings “do not support the use of ivermectin to treat mild to severe forms of COVID-19”. However, this conclusion is at odds with its findings.

… The study is a follow-up to an earlier, smaller study which showed promise. However, the promise has not, the authors say, been borne out.

… Despite this downbeat assessment, the new study did actually find a significant 32% improvement in ivermectin hospital patients achieving complete recovery, with 37% of ivermectin patients vs 28% of placebo patients achieving the outcome.

Latest articles

Swiss Policy Research … data from both Germany and Switzerland does show...
Kenji Yamamoto Recently, The Lancet published a study on the effectiveness of...
Kit Knightly Polio is on the front pages of British newspapers again...
Carey Gillam Glyphosate, a synthetic herbicide patented in 1974 by the Monsanto...
Suzanne Burdick A study published last week in Environment International showed 29...

Your donation helps us
stand up for health freedom!

Canada Health Alliance is volunteer run and 100% supported by the generous donations of those who share our concerns and value our work.

Stay up to date

Sign up to our newsletter to get the latest health-related news and events delivered straight to your inbox.

Become a CHA member

Become an active value-added member and trusted provider of medical and healthcare information and education by joining the CHA Membership Program.

Your donation helps us stand up for health freedom!

Canada Health Alliance is volunteer run and 100% supported by the generous donations of those who share our concerns and value our work.